Pipeline

Addressing the Consequences of Metabolic Complications

Allena is developing novel ways to deploy its oral enzyme technologies to target toxic metabolites that may cause or contribute to a range of serious medical problems including renal, cardiac and inflammatory complications. Our pipeline includes: